Logos Global Management »

Applied Therapeutics shares owned by Logos Global Management

Quarter-by-quarter ownership of Applied Therapeutics (APLT) shares owned by Logos Global Management from 13F filings

Historical chart of Logos Global Management investment in Applied Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Applied Therapeutics held by Logos Global Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Applied Therapeutics by Logos Global Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $5.6M 1.7M 3.35
2020-06-30 $455k 13k 36.11

More positions owned by Logos Global Management

Cytokinetics Com New (CYTK)
Apellis Pharmaceuticals (APLS)
Sarepta Therapeutics Call Option (SRPT)
Ideaya Biosciences (IDYA)
Argenx Se Sponsored Adr (ARGX)
Olema Pharmaceuticals (OLMA)
Immunovant (IMVT)
Structure Therapeutics Sponsored Ads (GPCR)
Rocket Pharmaceuticals (RCKT)
Rayzebio
Ambrx Biopharma
Karuna Therapeutics Ord
Immunocore Hldgs Ads (IMCR)
Dyne Therapeutics (DYN)
Morphosys Sponsored Ads Call Option (MOR)

View all positions for Logos Global Management

Top funds holding Applied Therapeutics

Alyeska Investment Group
Franklin Resources
VR Adviser
Knoll Capital Management
Propel Bio Management
Perceptive Advisors
Vanguard Group
Simplify Asset Management
Henderson Group
Logos Global Management
AIGH Capital Management
Opaleye Management
Millennium Management
Schonfeld Strategic Advisors
Point72 Asset Management

View all funds holding Applied Therapeutics